The IgE-dependent pathway in allergic transfusion reactions: involvement of donor blood allergens other than plasma proteins

International Journal of Hematology

Volumn 102, Issue 1, 2015, Pages 93-100

  Matsuyama, Nobuki ^a   Yasui, Kazuta ^a   Amakishi, Etsuko ^a   Hayashi, Tomoya ^a   Kuroishi, Ayumu ^a   Ishii, Hiroyuki ^a   Matsukura, Harumichi ^a   Tani, Yoshihiko ^a   Furuta, Rika A ^a   Hirayama, Fumiya ^a  

^a Block Blood Centre   (Japan)

Author keywords

Allergic transfusion reactions; Basophil activation test; Fish (mackerel) antigen; IgE dependent pathway

Indexed keywords

ALLERGEN; ALPHA 2 MACROGLOBULIN; CERULOPLASMIN; COLLAGEN TYPE 1; DASATINIB; FC EPSILON RECEPTOR; FC RECEPTOR; HAPTOGLOBIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; PLASMA PROTEIN; UNCLASSIFIED DRUG; BLOOD GROUP ANTIGEN; PROTEIN KINASE INHIBITOR;

ALLERGIC REACTION; ALLERGIC TRANSFUSION REACTION; ANAPHYLAXIS; ARTICLE; BASOPHIL; BASOPHIL ACTIVATION TEST; BLOOD COMPONENT; BLOOD DONOR; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; CERULOPLASMIN BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; IMMUNE FUNCTION TEST; SUPERNATANT; ADVERSE EFFECTS; DRUG EFFECTS; HYPERSENSITIVITY, IMMEDIATE; IMMUNOLOGY; METABOLISM; THROMBOCYTE TRANSFUSION; TRANSFUSION REACTION;

ALLERGENS; BASOPHILS; BLOOD GROUP ANTIGENS; BLOOD PROTEINS; DASATINIB; HUMANS; HYPERSENSITIVITY, IMMEDIATE; PLATELET TRANSFUSION; PROTEIN KINASE INHIBITORS; TRANSFUSION REACTION;

EID: 84937518105     PISSN: 09255710     EISSN: 18653774     Source Type: Journal    
DOI: 10.1007/s12185-015-1794-0     Document Type: Article

References (39)

1. Heddle NM, Klama L, Singer J, Richards C, Fedak P, Walker I, et al. The role of the plasma from platelet concentrates in transfusion reactions. N Engl J Med. 1994;331:625–8.
2. Hirayama F. Recent advances in laboratory assays for nonhemolytic transfusion reactions. Transfusion. 2010;50:252–63.
3. Geiger TL, Howard SC. Acetaminophen and diphenhydramine premedication for allergic and febrile nonhemolytic transfusion reactions: good prophylaxis or bad practice? Transfus Med Rev. 2007;21:1–12.
4. Savage WJ, Tobian AAR, Savage JH, Hamilton RG, Ness PM. Atopic predisposition of recipients in allergic transfusion reactions to apheresis platelets. Transfusion. 2011;51:2337–42.
5. Savage WJ, Tobian AAR, Savage JH, Wood RA, Schroeder JT, Ness PM. Scratching the surface of allergic transfusion reactions. Transfusion. 2013;53:1361–71.
6. Domen RE, Hoeltge GA. Allergic transfusion reactions: an evaluation of 273 consecutive reactions. Arch Pathol Lab Med. 2003;127:316–20.
7. Hirayama F. Current understanding of allergic transfusion reactions: incidence, pathogenesis, laboratory tests, prevention and treatment. Br J Haematol. 2013;160:434–44.
8. Metcalfe DD, Peavy RD, Gilfillan AM. Mechanisms of mast cell signaling in anaphylaxis. J Allergy Clin Immunol. 2009;124:639–48.
9. Gilfillan AM, Peavy RD, Metcalfe DD. Amplification mechanisms for the enhancement of antigen-mediated mast cell activation. Immuno Res. 2009;43:15–24.
10. Turner H, Kinet JP. Signalling through the high-affinity IgE receptor Fc epsilonR1. Nature. 1999;402:B24–30.
11. Koda Y, Watanabe Y, Soejima M, Shimada E, Nishimura M, Morishita K, et al. Simple PCRdetection of haptoglobin gene deletion in anhaptoglobinemic patients with antihaptoglobin antibody that causes anaphylactic transfusion reactions. Blood. 2000;95:1138–43.
12. Shimada E, Tadokoro K, Watanabe Y. Anaphylactic transfusion reactions in haptoglobin-deficient patients with IgE and IgG haptoglobin antibodies. Transfusion. 2002;42:766–73.
13. Arnold P, Schmidt MD, Howard F, Taswell MD, Gerald J, Gleich MD. Anaphylactic transfusion reactions associated with anti-IgA antibody. N Engl J Med. 1969;280:188–93.
14. Sander SG, Mallory D, Malamut D, Eckrich R. IgA anaphylactic transfusion reactions. Transfus Med Rev. 1995;1:1–8.
15. Lambin P, Le Pennec PY, Hauptmann G, Desaint O, Habibi B, Salmon C. Adverse transfusion reactions associated with a precipitating anti-C4 antibody of anti-Rodger specificity. Vox Sang. 1984;47:242–9.
16. Westhoff CM, Sipherd BD, Wylie DE, Toalson LD. Severe anaphylactic reactions following transfusions of platelets to a patient with anti-Ch. Transfusion. 1992;32:576–9.
17. Sandler SG. How I manage patients suspected of having had an IgA anaphylactic transfusion reaction. Transfusion. 2006;46:10–3.
18. Sandler SG, Eder AF, Goldman M, Winters JL. The entity of immunoglobulin A-related anaphylactic transfusion is not evidence based. Transfusion. 2015;55:199–204.
19. Wadhwa M, Seghatchian MJ, Lubenko A, Contreras M, Dilger P, Bird C, et al. Cytokine levels in platelet concentrates: quantitation by bioassays and immunoassays. Br J Heamatol. 1996;93:225–34.
20. Edvardsen L, Taaning E, Mynster T, Hvolris J, Drachman O, Nielsen HJ. Bioactive substances in buffy-coat-derived platelet pools stored in platelet-additive solutions. Br J Heamatol. 1998;103:445–8.
21. Phipps RP, Kaufmann J, Blumberg N. Platelet derived CD154 (CD40 ligand) and febrile responses to transfusion. Lancet. 2001;357:2023–4.
22. Wakamoto S, Fujihara M, Kuzuma K, Sato S, Kato T, Naohara T, et al. Biologic activity of RANTES in apheresis PLT concentrates and its involvement in nonhemolytic transfusion reactions. Transfusion. 2003;43:1038–46.
23. Garraud O, Hamzeh-Cognasse H, Cognasse F. Platelets and cytokines: how and why? Transfusion Clin Biol. 2012;19:104–8.
24. Jacobs JF, Baumert JL, Brons PP, Joosten I, Koppelman SJ, van Pampus EC. Anaphylaxis from passive transfer of peanut allergen in a blood product. N Engl J Med. 2011;364:1981–2.
25. Gao L, Sha Y, Yuan K, Ling L, Ai D, Ying H, et al. Allergic transfusion reaction caused by the shrimp allergen of donor blood: a case report. Transf Apheres Sci. 2014;50:68–70.
26. Aihara Y, Kotoyori T, Takahashi Y, Osuna H, Ohnuma S, Ikezawa Z. The necessity for dual food intake to provoke food-dependent exercise induced anaphylaxis (FEIAn): a case report of FEIAn with simultaneous intake of wheat and umeboshi. J Allergy Clin Immunol. 2001;107:1100–5.
27. Burks AW, Laubach S, Jones SM. Oral tolerance, food allergy, and immunotherapy: implications for future treatment. J Allergy Clin Immunol. 2008;121:1344–50.
28. Benhamou M, Feuillard J, Lortholary O, Bourgeois C, Michel L, LeGoff L, et al. Protein tyrosine kinases in activation signal of human basophils through the immunoglobulin E receptor type 1. J Leukoc Biol. 1996;59:461–70.
29. Eiseman E, Bolen JB. Engagement of the high-affinity IgE receptor activates src protein-related tyrosine kinases. Nature. 1992;355:78–80.
30. Costello PS, Turner M, Walters AE, Cunningham CN, Bauer PH, Downward J, et al. Critical role for the tyrosine kinase Syk in signaling through the high affinity IgE receptor of mast cells. Oncogene. 1996;13:2595–605.
31. Kepley CK, Wilson BS, Oliver JM. Identification of the Fc epsilonR1-activated tyrosine kinases Lyn, Syk, and Zap-70 in human basophils. J Allergy Clin Immunol. 1998;102:304–15.
32. Miura K, MacGlashan DW. Phosphatidylinositol-3 kinase regulates p21 ras activation during IgE-mediated stimulation of human basophils. Blood. 2000;96:2199–205.
33. Shah NP, Tran C, Lee FY, Chen P, Norris D, Sawyers VL. Overriding imatinib resistance with a novel ABL kinase inhibitor. Science. 2004;305:399–401.
34. Lombardo LJ, Lee FY, Chen P, Norris D, Barrish JC, Behnia K, et al. Discovery of N-(2-chloro-6-methyl-phenyl)-2-(6-(4-(2-hydroxyethyl)-piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide (BMS-354825), a dual Src/Abl kinase inhibitor with potent antitumor activity in preclinical assays. J Med Chem. 2004;47:6658–61.
35. Doggrell SA. BMS-354825: a novel drug with potential for the treatment of imatinib-resistant chronic myeloid leukaemia. Expert Opin Investig Drugs. 2005;14:89–91.
36. Gambacorti-Passerini C, Gasser M, Ahmed S, Assouline S, Scapozza L. Abl inhibitor BMS354825 binding mode in Abelson kinase revealed by molecular docking studies. Leukemia. 2005;19:1267–9.
37. Kneidinger M, Schmidt U, Rix U, Gleixner KV, Vales A, Baumgartner C, et al. The effects of dasatinib on IgE receptor-dependent activation and histamine release in human basophils. Blood. 2008;111:3097–107.
38. Sakaguchi M, Toda M, Ebihara T, Irie S, Hori H, Imai A, et al. IgE antibody to fish gelatin (type 1 collagen) in patients with fish allergy. J Allergy Clin Immunol. 2000;106:579–84.
39. Matsuyama N, Hirayama F, Wakamoto S, Yasui K, Furuta RA, Kimura T, et al. Application of the basophil activation test in the analysis of allergic transfusion reactions. Transfus Med. 2009;19:274–7.